198 related articles for article (PubMed ID: 17549049)
1. Activation of the ERK signalling pathway contributes to the adaptive changes in rat hearts during naloxone-induced morphine withdrawal.
Almela P; Milanés MV; Laorden ML
Br J Pharmacol; 2007 Jul; 151(6):787-97. PubMed ID: 17549049
[TBL] [Abstract][Full Text] [Related]
2. Tyrosine hydroxylase phosphorylation after naloxone-induced morphine withdrawal in the left ventricle.
Almela P; Victoria Milanés M; Luisa Laorden M
Basic Res Cardiol; 2009 Jul; 104(4):366-76. PubMed ID: 19104749
[TBL] [Abstract][Full Text] [Related]
3. Naloxone-precipitated morphine withdrawal evokes phosphorylation of heat shock protein 27 in rat heart through extracellular signal-regulated kinase.
Almela P; Martínez-Laorden E; Atucha NM; Milanés MV; Laorden ML
J Mol Cell Cardiol; 2011 Jul; 51(1):129-39. PubMed ID: 21530534
[TBL] [Abstract][Full Text] [Related]
4. Morphine withdrawal-induced c-fos expression in the heart: a peripheral mechanism.
González-Cuello A; Milanés MV; Castells MT; Laorden ML
Eur J Pharmacol; 2004 Mar; 487(1-3):117-24. PubMed ID: 15033383
[TBL] [Abstract][Full Text] [Related]
5. Morphine withdrawal activates hypothalamic-pituitary-adrenal axis and heat shock protein 27 in the left ventricle: the role of extracellular signal-regulated kinase.
Martínez-Laorden E; Hurle MA; Milanés MV; Laorden ML; Almela P
J Pharmacol Exp Ther; 2012 Sep; 342(3):665-75. PubMed ID: 22647273
[TBL] [Abstract][Full Text] [Related]
6. Cross-talk between protein kinase A and mitogen-activated protein kinases signalling in the adaptive changes observed during morphine withdrawal in the heart.
Almela P; Atucha NM; Milanés MV; Laorden ML
J Pharmacol Exp Ther; 2009 Sep; 330(3):771-82. PubMed ID: 19567779
[TBL] [Abstract][Full Text] [Related]
7. Regulation of extracellular signal-regulated kinases (ERKs) by naloxone-induced morphine withdrawal in the brain stress system.
Núñez C; Castells MT; Laorden ML; Milanés MV
Naunyn Schmiedebergs Arch Pharmacol; 2008 Oct; 378(4):407-20. PubMed ID: 18548233
[TBL] [Abstract][Full Text] [Related]
8. Changes in c-fos expression in the rat heart during morphine withdrawal. Involvement of alpha2-adrenoceptors.
González-Cuello A; Milanés MV; Aviles M; Laorden ML
Naunyn Schmiedebergs Arch Pharmacol; 2004 Jul; 370(1):17-25. PubMed ID: 15249992
[TBL] [Abstract][Full Text] [Related]
9. Differential involvement of 3', 5'-cyclic adenosine monophosphate-dependent protein kinase in regulation of Fos and tyrosine hydroxylase expression in the heart after naloxone induced morphine withdrawal.
Almela P; Cerezo M; González-Cuello A; Milanés MV; Laorden ML
Naunyn Schmiedebergs Arch Pharmacol; 2007 Jan; 374(4):293-303. PubMed ID: 17216288
[TBL] [Abstract][Full Text] [Related]
10. Involvement of 3',5'-cyclic adenosine monophosphate-dependent protein kinase in regulation of Fos expression and tyrosine hydroxylase levels during morphine withdrawal in the hypothalamic paraventricular nucleus and medulla oblongata catecholaminergic cell groups.
Benavides M; Laorden ML; Milanés MV
J Neurochem; 2005 Jan; 92(2):246-54. PubMed ID: 15663473
[TBL] [Abstract][Full Text] [Related]
11. [Activation of the spinal extracellular signal-regulated kinase is involved in morphine dependence and naloxone-precipitated withdrawal response].
He JH; Cao JL; Xu YB; Song XS; Ding HL; Zeng YM
Sheng Li Xue Bao; 2005 Oct; 57(5):557-65. PubMed ID: 16220193
[TBL] [Abstract][Full Text] [Related]
12. Cross talk between nitric oxide and ERK1/2 signaling pathway in the spinal cord mediates naloxone-precipitated withdrawal in morphine-dependent rats.
Cao JL; Liu HL; Wang JK; Zeng YM
Neuropharmacology; 2006 Aug; 51(2):315-26. PubMed ID: 16712881
[TBL] [Abstract][Full Text] [Related]
13. Increase of tyrosine hydroxylase levels and activity during morphine withdrawal in the heart.
González-Cuello A; Milanés MV; Laorden ML
Eur J Pharmacol; 2004 Dec; 506(2):119-28. PubMed ID: 15588731
[TBL] [Abstract][Full Text] [Related]
14. A neuroactive steroid, dehydroepiandrosterone sulfate, prevents the development of morphine dependence and tolerance via c-fos expression linked to the extracellular signal-regulated protein kinase.
Ren X; Noda Y; Mamiya T; Nagai T; Nabeshima T
Behav Brain Res; 2004 Jul; 152(2):243-50. PubMed ID: 15196791
[TBL] [Abstract][Full Text] [Related]
15. Naloxone-precipitated withdrawal enhances ERK phosphorylation in prefrontal association cortex and accumbens nucleus of morphine-dependent mice.
Li T; Hou Y; Cao W; Yan CX; Chen T; Li SB
Neurosci Lett; 2010 Jan; 468(3):348-52. PubMed ID: 19922770
[TBL] [Abstract][Full Text] [Related]
16. Regulation of tyrosine hydroxylase levels and activity and Fos expression during opioid withdrawal in the hypothalamic PVN and medulla oblongata catecholaminergic cell groups innervating the PVN.
Benavides M; Laorden ML; García-Borrón JC; Milanés MV
Eur J Neurosci; 2003 Jan; 17(1):103-12. PubMed ID: 12534973
[TBL] [Abstract][Full Text] [Related]
17. Cardiac adverse effects of naloxone-precipitated morphine withdrawal on right ventricle: role of corticotropin-releasing factor (CRF) 1 receptor.
Navarro-Zaragoza J; Martínez-Laorden E; Mora L; Hidalgo J; Milanés MV; Laorden ML
Toxicol Appl Pharmacol; 2014 Feb; 275(1):28-35. PubMed ID: 24398105
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the bed nucleus of the stria terminalis activated by the central nucleus of the amygdala in the negative affective component of morphine withdrawal in rats.
Nakagawa T; Yamamoto R; Fujio M; Suzuki Y; Minami M; Satoh M; Kaneko S
Neuroscience; 2005; 134(1):9-19. PubMed ID: 15939543
[TBL] [Abstract][Full Text] [Related]
19. Expression of c-Fos in the rat central amygdala accompanies the acquisition but not expression of conditioned place aversion induced by withdrawal from acute morphine dependence.
Jin C; Araki H; Nagata M; Shimosaka R; Shibata K; Suemaru K; Kawasaki H; Gomita Y
Behav Brain Res; 2005 Jun; 161(1):107-12. PubMed ID: 15904717
[TBL] [Abstract][Full Text] [Related]
20. Activation of c-fos expression in the heart after morphine but not U-50,488H withdrawal.
González-Cuello A; Milanés MV; Castells MT; Laorden ML
Br J Pharmacol; 2003 Feb; 138(4):626-33. PubMed ID: 12598416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
